Nine-month clinical outcomes in patients with diabetes treated with polymer free sirolimus-eluting stents and dual-anti platelet therapy (DAPT) for 6 months versus DAPT for 12 months

被引：0
|
作者：
Krackhardt, Markus Florian [1 ]
Waliszewski, Matt [2 ]
Pons, Maxime [3 ]
Verdun, Francois [4 ]
Pansieri, Michel [5 ]
Rios, Xabobe Flores [6 ]
Lozano, Fernando [7 ]
Boxberger, Michael [8 ]
Kherad, Behrouz [9 ]
机构：
[1] Charite, Augustenburger Pl, Berlin, Germany
[2] B Braun Vasc Syst, Berlin, Germany
[3] Clin Millenaire, Montpellier, France
[4] Hop Albert Schweitzer, Fdn Maison Diaconat, Cardiol, Colmar, France
[5] Ctr Hosp Avigon, Avignon, France
[6] Complejo Hosp Univ A Coruna, Coruna, Spain
[7] Univ Gen Hosp Ciudad Real, Ciudad Real, Spain
[8] B Braun, Berlin, Germany
[9] Charite, Berlin, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 70卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2017.09.966
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-731
引用
收藏
页码：B310 / B311
页数：2
相关论文
共 41 条
  • [1] Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6-month vs. 12-month dual-antiplatelet therapy (DAPT)
    Krackhardt, F.
    Waliszewski, M.
    Rischner, J.
    Piot, C.
    Pansieri, M.
    Ruiz-Povede, F. L.
    Boxberger, M.
    Noutsias, M.
    Rios, X. F.
    Kherad, B.
    [J]. HERZ, 2019, 44 (05) : 433 - 439
  • [2] Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT); [Klinische Ergebnisse nach Behandlung mit polymerfreien sirolimusfreisetzenden Stents und 6‑ vs. 12‑monatiger dualer Thrombozytenaggregationshemmertherapie (DAPT) bei Diabetes]
    Krackhardt F.
    Waliszewski M.
    Rischner J.
    Piot C.
    Pansieri M.
    Ruiz-Poveda F.L.
    Boxberger M.
    Noutsias M.
    Ríos X.F.
    Kherad B.
    [J]. Herz, 2019, 44 (5) : 433 - 439
  • [3] Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry
    Lipiecki, Janusz
    Rampat, Rajiv
    Piot, Christophe
    Benamer, Hakim
    Brunelle, Francois
    Lefevre, Thierry
    El Mahmoud, Rami
    Varenne, Olivier
    Gommeaux, Antoine
    Malquarti, Vincent
    Angoulvant, Denis
    Cruchon, Clauset
    Oldroyd, Keith
    Spaulding, Christian
    [J]. JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (05): : E363 - E368
  • [4] NINE-MONTH CLINICAL OUTCOMES IN DIALYSIS PATIENTS FOLLOWING POLYMER-FREE SIROLIMUS-ELUTING STENT IMPLANTATIONS
    Krackhardt, Florian
    Waliszewski, Matthias
    Kherad, Behrouz
    Barth, Claudia
    Marcelli, Daniele
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [5] Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
    Zhang, Haijun
    Wang, Xiangfei
    Deng, Wei
    Wang, Shenguo
    Ge, Junbo
    Toft, Egon
    [J]. MEDICINE, 2016, 95 (38)
  • [6] Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients
    Tao, Ling
    Li, Zhanquan
    Yin, Zhiyong
    Lin, Wenhua
    Liu, Yin
    Li, Hui
    Yu, Bo
    Li, Wei
    Xu, Bo
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 : 966 - 975
  • [7] Comparision of efficacy and safety of 3-month dual antiplatelet therapy(DAPT) versus 6-month DAPT following Coroflex ISAR sirolimus-eluting stent(C-SES) implantation
    Lee, J. H.
    Yoon, M. H.
    Tahk, S. J.
    Shin, J. H.
    Hwang, G. S.
    Choi, S. Y.
    Choi, B. J.
    Lim, H. S.
    Yang, H. M.
    Park, J. S.
    Seo, K. W.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 136 - 136
  • [8] Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial
    Yuan Fei
    Chen Xin
    Song Xiantao
    Wang Dongqi
    Zhang Zheng
    Li Weimin
    Li Zhanquan
    Li Hui
    Chen Xinyi
    Huo Yong
    Wang Lefeng
    Lu Caiyi
    Lu Qinghua
    Xu Bo
    Li Wei
    Lyu Shuzheng
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (14) : 2561 - 2566
  • [9] Five-year outcomes in patients with diabetes mellitus treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents
    Iglesias, J. F.
    Heg, D.
    Roffi, M.
    Tueller, D.
    Lanz, J.
    Rigamonti, F.
    Muller, O.
    Moarof, I.
    Cook, S.
    Weilenmann, D.
    Kaiser, C.
    Valgimigli, M.
    Jueni, P.
    Windecker, S.
    Pilgrim, T.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1257 - 1257
  • [10] Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
    Iglesias, Juan F.
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Lanz, Jonas
    Rigamonti, Fabio
    Mueller, Olivier
    Moarof, Igal
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Cuculi, Florim
    Valgimigli, Marco
    Juni, Peter
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
12345